Trial Profile
Comparison of MECHANISM of Early and Late Vascular Responses Following Treatment of ST-elevation Acute Myocardial Infarction With Two Different Everolimus-eluting Stents: Randomized Controlled Trial Between Biodegradable Polymer and Durable Polymer Stent
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Jul 2022
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- Acronyms MECHANISM-AMI-RCT
- 29 May 2020 Status changed from not yet recruiting to active, no longer recruiting.
- 12 Nov 2018 New trial record